Viewing Study NCT02809534


Ignite Creation Date: 2025-12-25 @ 2:33 AM
Ignite Modification Date: 2026-03-02 @ 8:37 PM
Study NCT ID: NCT02809534
Status: UNKNOWN
Last Update Posted: 2016-09-07
First Post: 2016-06-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Anlotinib in Patients With Hepatocellular Carcinoma
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ALTN-08-II
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators